December 2, 2025 A new, groundbreaking six-paper series from The Lancet HIV and The Lancet Global Health journals, co-authored by more than two dozen African and global experts, outlines a roadmap for sustainable, nationally led HIV prevention across the continent. December 3, 2025 — At the 2025 International Conference on AIDS and Sexually Transmitted Infections in Africa (ICASA), Malawi’s...
Category: Global News
Post
From Relief to Resilience! NAC Advocates for Sustainable, African-Focused Health Systems
At the Africa’s Roadmap to Self-Reliant Healthcare Webinar on August 27, 2025, Dr. Beatrice Matanje, CEO of the National AIDS Commission, delivered a compelling call to action below: The path ahead is not paved with aid but with audacity. Africa has the talent, resolve, and ingenuity to build health systems that serve our people. Let’s...
Post
The Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low-and Middle-Income Countries.
Malawi National AIDS Commissions joins global experts in describing this as a pivotal moment on the road to ending AIDS as a public health threat— ensuring lifesaving innovation reaches those who need it most, wherever they live. The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) has announced that it has signed...
Post
HIV Long term injectable drug approved! The National AIDS Commission appeals for continued adherence to present PrEP.
Exciting news! The United States Food and Drug Administration (FDA) has approved an injectable drug for HIV prevention called Lenacapavir (LEN) as Pre-Exposure Prophylaxis. The drug needs to be injected just twice a year for the HIV Negative at-risk population groups. The approval means the drug could be rolled out globally to help overcome barriers...